Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Brugada syndrome (BrS) is an autosomal dominant inherited arrhythmia characterized by coved ST-segment elevation in the right precordial leads and increased risk of ventricular fibrillation and sudden death. KCNJ8 encodes the Kir6.1 subunit of the cardiac ATP-sensitive potassium (KATP) channel, and has emerged as a susceptibility gene for J-wave syndromes including BrS (and early repolarization syndrome).
Genetic screening of 204 unrelated BrS and ERS probands identified the same missense variant c.1265C>T (p.Ser422Leu) in 3 BrS and 1 ERS probands, absent in 430 ethnically matched controls (PMID:22056721). An earlier study also reported p.Ser422Leu in one BrS case and one ERS case but not in 600 controls (PMID:20558321). In a kindred with early repolarization and atrial fibrillation, p.Ser422Leu co-segregated with disease in an affected relative (PMID:22562657).
Segregation analysis reveals at least one affected relative with the variant, consistent with autosomal dominant inheritance. Overall, four unrelated BrS probands and one segregation event support a moderate level of genetic evidence.
Functional assays in TSA201 cells co-expressing mutant Kir6.1-S422L with SUR2A-WT demonstrated a two-fold increase in glibenclamide-sensitive KATP current and a marked shift in ATP‐inhibition (IC₅₀ 785.5 ± 2 µM vs 38.4 ± 3 µM for WT), indicating gain of channel function under normoxic conditions (PMID:22056721). Conversely, transgenic mice overexpressing Kir6.1-S422L exhibited ECG changes but no clear J-wave phenotype, suggesting species- or context-specific effects (PMID:28928055).
Integration of genetic and experimental data supports a pathogenic gain-of-function mechanism for KCNJ8-p.Ser422Leu in Brugada syndrome. While animal models yield mixed findings, robust human cellular electrophysiology aligns with the clinical phenotype.
Key Take-home: The KCNJ8 p.Ser422Leu variant demonstrates a gain-of-function mechanism and meets criteria for inclusion in Brugada syndrome genetic testing.
Gene–Disease AssociationModerateFour unrelated BrS probands identified with p.Ser422Leu [PMID:22056721], one segregation event [PMID:22562657], and concordant functional gain-of-function data Genetic EvidenceModerate4 BrS probands with a recurrent missense variant and segregation in one family Functional EvidenceModerateCellular patch-clamp studies demonstrate gain-of-function (2-fold current increase, shifted ATP IC₅₀) consistent with disease mechanism |